Why Is Editas Medicine, Inc. (EDIT) Among the Top CRISPR Stocks to Invest In?

Published on 30 Dec 2024 on Insider Monkey · via Yahoo Finance

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are goi...

Insider Monkey · via Yahoo Finance 30 Dec 2024

Editas stock falls as it ends development of reni-cel for SCD and TDT following failed attempts t...

Zacks · via Yahoo Finance 16 Dec 2024

Big changes, including major layoffs, are coming at Editas Medicine Inc. as the biotech lays off ...

The Business Journals 13 Dec 2024

On Thursday, Editas Medicine Inc. (NASDAQ:EDIT) announced a strategic realignment to focus on in...

Benzinga · via Yahoo Finance 13 Dec 2024

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge...

Insider Monkey · via Yahoo Finance 31 Oct 2024

Overview of Recent Transaction by State Street Corp On September 30, 2024, State Street Corp exec...

GuruFocus.com · via Yahoo Finance 17 Oct 2024

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 19 Jun 2024

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 19 Jun 2024

Erick Lucera, the EVP, Chief Financial Officer of Editas Medicine Inc (NASDAQ:EDIT), sold 22,337 ...

GuruFocus.com via Yahoo Finance 23 May 2024

On May 13, 2024, Jessica Hopfield, Director at Editas Medicine Inc (NASDAQ:EDIT), purchased 45,00...

GuruFocus.com via Yahoo Finance 16 May 2024